Brief: Beta Drugs Receives Oncology Portfolio Approvals In Azerbaijan
22/09/2026 04:32
BRIEF-Beta Drugs Receives Oncology Portfolio Approvals In Azerbaijan Sept 22 (Reuters) - Beta Drugs Ltd BTAD.NS:
BETA DRUGS - RECEIVES ONCOLOGY PORTFOLIO APPROVALS IN AZERBAIJAN
BETA DRUGS - WORKING TO SECURE INITIAL ONCOLOGY BUSINESS FROM AZERBAIJAN THIS FINANCIAL YEAR
Source text: ID:nNSE5j7R9K
Further company coverage: BTAD.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beta Drugs
See all newsBrief: Beta Drugs Receives Oncology Portfolio Approvals In Azerbaijan
India's Beta Drugs jumps after regulatory milestones in Azerbaijan, Philippines
Brief: Beta Drugs Achieves Regulatory Milestones In Azerbaijan And Philippines
Brief: Beta Drugs To Buy 66.09% Of Nivian Life Sciences For 694 MLN Rupees
Brief: Beta Drugs Receives Dcgi Approval For Methotrexate Oral Solution